JP2011517666A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011517666A5 JP2011517666A5 JP2011500764A JP2011500764A JP2011517666A5 JP 2011517666 A5 JP2011517666 A5 JP 2011517666A5 JP 2011500764 A JP2011500764 A JP 2011500764A JP 2011500764 A JP2011500764 A JP 2011500764A JP 2011517666 A5 JP2011517666 A5 JP 2011517666A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrene
- peptide
- agent
- composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3863408P | 2008-03-21 | 2008-03-21 | |
| US61/038,634 | 2008-03-21 | ||
| PCT/US2009/000613 WO2009117041A2 (en) | 2008-03-21 | 2009-01-30 | Use of pyrene to carry peptides across the blood brain barrier |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011517666A JP2011517666A (ja) | 2011-06-16 |
| JP2011517666A5 true JP2011517666A5 (enExample) | 2013-04-11 |
Family
ID=40974375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011500764A Pending JP2011517666A (ja) | 2008-03-21 | 2009-01-30 | 血液脳関門を横断してペプチドを運搬するためのピレンの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20090238754A1 (enExample) |
| EP (1) | EP2268314A2 (enExample) |
| JP (1) | JP2011517666A (enExample) |
| CN (1) | CN102014967A (enExample) |
| AU (1) | AU2009226161A1 (enExample) |
| CA (1) | CA2718860A1 (enExample) |
| MX (1) | MX2010010266A (enExample) |
| WO (1) | WO2009117041A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002320045B2 (en) | 2001-05-31 | 2008-05-08 | Adlyfe, Inc. | Misfolded protein sensor method |
| US20050026165A1 (en) | 2001-05-31 | 2005-02-03 | Cindy Orser | Detection of conformationally altered proteins and prions |
| JP5097206B2 (ja) * | 2006-07-28 | 2012-12-12 | エイディーライフ インコーポレイティッド | 診断および治療のためのペプチドプローブ |
| US20090274621A1 (en) * | 2008-03-21 | 2009-11-05 | Adlyfe, Inc | Use of pyrene to carry non-peptide agents across the blood brain barrier |
| CN102365295A (zh) * | 2009-01-30 | 2012-02-29 | 阿德利夫股份有限公司 | 构象动力肽 |
| WO2013025261A2 (en) * | 2011-04-06 | 2013-02-21 | Georgia Tech Research Corporation | Fluorogenic peptide probes and assays |
| EP2712425A2 (en) | 2011-04-27 | 2014-04-02 | Adlyfe, Inc. | Ocular detection of amyloid proteins |
| JP6144673B2 (ja) | 2011-06-03 | 2017-06-07 | オフィディオン インコーポレイティド | 血液脳関門を通過して輸送するための組成物及び方法 |
| PL230602B1 (pl) | 2013-04-04 | 2018-11-30 | Centrum Badan Molekularnych I Makromolekularnych Polskiej Akademii Nauk | Kwas (E)-3-arylo-3-oksoprop-1-enylo-2-fosfonowy i jego pochodne, sposob ich wytwarzania oraz ich zastosowanie |
| PL223918B1 (pl) | 2013-05-28 | 2016-11-30 | Centrum Badań Molekularnych i Makromolekularnych Polskiej Akademii Nauk | 3-Arylo-2-fosforylo podstawione 1-indanony i sposób ich wytwarzania |
| WO2018226992A1 (en) | 2017-06-07 | 2018-12-13 | Adrx, Inc. | Tau aggregation inhibitors |
| CA3073062A1 (en) | 2017-08-18 | 2019-02-21 | Adrx, Inc. | Tau aggregation peptide inhibitors |
| CN110759974B (zh) * | 2018-07-25 | 2021-11-09 | 中国医学科学院药物研究所 | 一种磷脂-聚乙二醇-狂犬病毒衍生肽聚合物，其制备方法及应用 |
| US10568907B1 (en) | 2018-10-09 | 2020-02-25 | Carol J. Buck | Methods of treating basal cell carcinoma and glioblastoma |
| US10369170B1 (en) | 2018-10-09 | 2019-08-06 | Carol J. Buck | Methods of treating basal cell carcinoma and glioblastoma |
| AU2020398216A1 (en) | 2019-12-04 | 2022-06-30 | The Board Of Trustees Of The Leland Stanford Junior University | Enhancing blood-brain barrier drug transport by targeting endogenous regulators |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4822733A (en) * | 1985-05-28 | 1989-04-18 | Amoco Corporation | Lifetime-resolved assay procedures |
| US5260308A (en) * | 1991-11-06 | 1993-11-09 | Mayo Foundation For Medical Education And Research | Method to increase permeability of the blood-nerve/brain barriers to proteins |
| US5604198A (en) * | 1994-05-12 | 1997-02-18 | Poduslo; Joseph F. | Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents |
| US5670477A (en) * | 1995-04-20 | 1997-09-23 | Joseph F. Poduslo | Method to enhance permeability of the blood/brain blood/nerve bariers to therapeutic agents |
| JP2001515044A (ja) * | 1997-08-14 | 2001-09-18 | ザ・レジェンツ・オブ・ザ・ユニバーシティー・オブ・カリフォルニア | 蛍光アミロイドＡβペプチドとその使用 |
| US6761888B1 (en) * | 2000-05-26 | 2004-07-13 | Neuralab Limited | Passive immunization treatment of Alzheimer's disease |
| US20030162698A1 (en) * | 1999-01-27 | 2003-08-28 | Alphonse Galdes | Methods and compositions for treating dopaminergic and gaba-nergic disorders |
| WO2001074374A1 (en) * | 2000-04-04 | 2001-10-11 | Mayo Foundation For Medical Education And Research | Methods for detecting plaques in vivo |
| US7311893B2 (en) * | 2000-07-25 | 2007-12-25 | Neurochem (International) Limited | Amyloid targeting imaging agents and uses thereof |
| US7470420B2 (en) * | 2000-12-05 | 2008-12-30 | The Regents Of The University Of California | Optical determination of glucose utilizing boronic acid adducts |
| JP4029041B2 (ja) * | 2001-01-10 | 2008-01-09 | アメリカ合衆国 | ｓＦＲＰおよびｓＦＲＰと相互作用するペプチドモチーフならびにそれらの使用法 |
| GB0106953D0 (en) * | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
| WO2002094191A2 (en) * | 2001-05-23 | 2002-11-28 | New York University | Detection of alzheimer's amyloid by magnetic resonance imaging |
| US20050026165A1 (en) * | 2001-05-31 | 2005-02-03 | Cindy Orser | Detection of conformationally altered proteins and prions |
| US7851593B2 (en) * | 2002-01-04 | 2010-12-14 | Becton, Dickinson And Company | Binding proteins as biosensors |
| CN1688299A (zh) * | 2002-01-29 | 2005-10-26 | 普罗特米克斯公司 | 抑制细胞毒性蛋白构象异构体 |
| WO2005004794A2 (en) * | 2003-06-09 | 2005-01-20 | Alnylam Pharmaceuticals Inc. | Method of treating neurodegenerative disease |
| US20050009109A1 (en) * | 2003-07-08 | 2005-01-13 | Stanford University | Fluorophore compounds and their use in biological systems |
| WO2005035549A2 (en) * | 2003-10-14 | 2005-04-21 | Kernel Biopharma Inc. | Amiphiphylic peptide-pna conjugates for the delivery of pna through the blood brain barrier |
| US20080038349A1 (en) * | 2004-02-17 | 2008-02-14 | Lamensdorf Itschak | Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase |
| WO2006076683A2 (en) * | 2005-01-13 | 2006-07-20 | Novartis Vaccines And Diagnostics Inc. | Isolation and detection of pathogenic prions |
| EP1853915B1 (en) * | 2005-02-15 | 2011-10-12 | Adlyfe, Inc. | Method for detecting misfolded proteins and prions |
| JP4295338B2 (ja) * | 2005-03-31 | 2009-07-15 | 財団法人野口研究所 | 質量分析法 |
| US7388747B2 (en) * | 2006-04-07 | 2008-06-17 | Inventec Corporation | Heat plate fixing structure |
| JP5097206B2 (ja) * | 2006-07-28 | 2012-12-12 | エイディーライフ インコーポレイティッド | 診断および治療のためのペプチドプローブ |
| US20090274621A1 (en) * | 2008-03-21 | 2009-11-05 | Adlyfe, Inc | Use of pyrene to carry non-peptide agents across the blood brain barrier |
-
2009
- 2009-01-30 AU AU2009226161A patent/AU2009226161A1/en not_active Abandoned
- 2009-01-30 WO PCT/US2009/000613 patent/WO2009117041A2/en not_active Ceased
- 2009-01-30 EP EP09722213A patent/EP2268314A2/en not_active Withdrawn
- 2009-01-30 JP JP2011500764A patent/JP2011517666A/ja active Pending
- 2009-01-30 CN CN2009801166660A patent/CN102014967A/zh active Pending
- 2009-01-30 US US12/363,254 patent/US20090238754A1/en not_active Abandoned
- 2009-01-30 CA CA2718860A patent/CA2718860A1/en not_active Abandoned
- 2009-01-30 MX MX2010010266A patent/MX2010010266A/es active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2547692T5 (en) | PEPTID DERIVATIVES, PREPARING thereof, AND APPLICATIONS THEREOF | |
| US20220048961A1 (en) | Transferrin receptor targeting peptides | |
| JP5947801B2 (ja) | アミロイド斑形成の阻害に有用なペプチド化合物 | |
| AU2009327338B2 (en) | TFPI inhibitors and methods of use | |
| Abdul Ghaffar et al. | Levofloxacin and indolicidin for combination antimicrobial therapy | |
| CN109563128B (zh) | 恶性肿瘤靶向肽 | |
| JP7710740B2 (ja) | ペプチド組成物 | |
| CA2909080C (en) | Methods, uses and compositions of tie2 agonists | |
| JP2010524849A5 (enExample) | ||
| JP2014525901A5 (enExample) | ||
| JP2013100315A (ja) | アミリン誘導体 | |
| JP2013522291A5 (enExample) | ||
| BRPI0620806B1 (pt) | A complex and composition comprising a peptide and a charge molecule, and use of said composition | |
| US20150238431A1 (en) | Icam-1 targeting elps | |
| HK1251512A1 (zh) | 靶向蛋白造影剂、其制备方法及用途 | |
| JP2015500823A (ja) | Ｇｌｐ−１アゴニスト | |
| CN105745219B (zh) | 结合β淀粉状蛋白的肽及其用于治疗和诊断阿尔茨海默痴呆症的用途 | |
| WO2016176426A1 (en) | Thrombus imaging aptamers and methods of using same | |
| WO2021116079A1 (en) | Peptides binding to ldl-receptor as carriers for crossing the blood brain barrier | |
| Harrison et al. | Helical cyclic pentapeptides constrain HIV-1 Rev peptide for enhanced RNA binding | |
| JP2023546383A (ja) | アネキシンａ５組成物及び方法 | |
| AU2021368859A9 (en) | Peptide-based delivery of agents | |
| CA2939658C (en) | Peptides and methods of use | |
| WO2024243639A1 (en) | Autophagy-inducing peptides | |
| CN113195704A (zh) | 用于治疗癌症的肽治疗剂及其用途 |